Arcadia Biosciences, Inc.
RKDA· Nasdaq
Released Aug 16, 2021, after the close
10-Q filed Aug 16, 2021, 47 days after period end · 0001564590-21-044701
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $1.41M | $281.00K | $203.00K | $436.00K |
| Net Income | -$5.26M | -$9.69M | $4.24M | -$6.67M |
| EPS Diluted |
Arcadia Biosciences, Inc. · CIK 1469443 · Engraved from SEC EDGAR
| -$0.24 |
| -$1.04 |
| $0.84 |
| -$2.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.